Categories: Alzheimer's

7/10/2018

WSJ offers caution early and often in coverage of latest experimental Alzheimer’s drug

2/19/2018

ABC downplays gloomy context in reporting ‘remarkable’ BACE1 finding for Alzheimer’s

9/2/2016

Unlike many other news sites, NPR resists overstating results of Alzheimer’s study

7/26/2016

More backstory needed on study of ‘brain training’ benefits for dementia

1 9/28/2015

With just 226 words, NYT can’t deliver needed context on Alzheimer’s agitation study

9/16/2015

Resveratrol “may slow Alzheimer’s”? Not really

9/16/2015

Over-the-top headline aside, CNN frames resveratrol/Alzheimer’s study in cautious, accurate language

1 8/15/2015

FDA approves first computer-based dementia assessment aid; thorough Post report falls just short on key aspects of coverage

1 8/12/2015

Important Alzheimer’s topic needed a second source for context

1 7/24/2015

WSJ business story on Alzheimer’s drugs missed key aspects of health angle

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Alan Cassels @AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680 Retweet on Twitter 13614314893264076806 Like on Twitter 13614314893264076808 Twitter 1361431489326407680

Retweet on Twitter HealthNewsReview.org Retweeted

RxISK @RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843 Retweet on Twitter 13614204592841318439 Like on Twitter 136142045928413184319 Twitter 1361420459284131843

HealthNewsReview.org @HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532 Retweet on Twitter 13602149497049825325 Like on Twitter 136021494970498253210 Twitter 1360214949704982532